Viatris recalls

Viatris has 26 recalls on record with the FDA and USDA, the earliest in 2021 and the latest reported on 28 Oct 2026. 13 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls26since 2021
Last 12 months2reported
Class I14% of total
Ongoing13latest 28 Oct 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 4%Class II 22 85%Class III 3 12%

By year

Ongoing viatris recalls

13 active

All viatris recalls, newest first

26 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIITelmisartan and Amlodipine, Tablets, USP, 40mg/5 mg recalled by ViatrisTelmisartan And AmlodipineViatrisPotency & AssayNationwide
DrugCLASS IIXanax XR, alprazolam, extended-release tablets, 3 mg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IICardura XL (doxazosin) extended release tablets 4 mg recalled by ViatrisCarduraViatrisPotency & AssayNationwide
DrugCLASS IICardura XL (doxazosin) extended release tablets 8 mg recalled by ViatrisCarduraViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 25 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 75 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 88 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 137 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 175 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 112 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 200 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 125 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 50 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 100 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IILevothyroxine Sodium Tablets USP, 150 mcg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IICardura XL (doxazosin) extended release tablets 4mg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IICardura XL (doxazosin) extended release tablets 8mg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IIIValacyclovir Tablets USP, 500 mg recalled by ViatrisValacyclovir HydrochlorideViatrisOtherNationwide
DrugCLASS IILevsin injection (hyoscyamine sulfate injection, USP) recalledViatrisManufacturing (CGMP) DeviationsPA
DrugCLASS IICarvedilol Tablets, USP, 25 mg recalled by ViatrisViatrisOtherNationwide
DrugCLASS IOctreotide Acetate Injection 500 mcg/mL recalled by ViatrisOctreotide AcetateViatrisParticulate MatterNationwide
DrugCLASS IIAmpicillin for Injection recalled by ViatrisViatrisParticulate MatterNationwide
DrugCLASS IIXanax XR (alprazolam) extended-release tablets, 3 mg recalled by ViatrisViatrisPotency & AssayNationwide
DrugCLASS IIalprazolam XR extended-release tablets, 3 mg recalled by ViatrisAlprazolamViatrisPotency & AssayNationwide
DrugCLASS IILyrica CR (pregabalin) extended release tablets, 330 mg recalledViatrisPotency & AssayNationwide
DrugCLASS IIICandesartan Cilexetil Tablets, USP 16 mg recalled by ViatrisCandesartan CilexetilViatrisPotency & AssayNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.